BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 18713478)

  • 1. Pharmaceutical industry marketing: understanding its impact on women's health.
    Sufrin CB; Ross JS
    Obstet Gynecol Surv; 2008 Sep; 63(9):585-96. PubMed ID: 18713478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gendering the migraine market: do representations of illness matter?
    Kempner J
    Soc Sci Med; 2006 Oct; 63(8):1986-97. PubMed ID: 16790309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations and advertising: controversies in the prescribing of hormone replacement therapy.
    Katz A
    Health Care Women Int; 2003 Dec; 24(10):927-39. PubMed ID: 14742130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmaceutical corporation and the 'good work' of managing women's bodies.
    Padamsee TJ
    Soc Sci Med; 2011 Apr; 72(8):1342-50. PubMed ID: 21435768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 6. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
    Civaner M
    Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Student understanding of the relationship between the health professions and the pharmaceutical industry.
    Monaghan MS; Galt KA; Turner PD; Houghton BL; Rich EC; Markert RJ; Bergman-Evans B
    Teach Learn Med; 2003; 15(1):14-20. PubMed ID: 12632703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
    Kyle GJ; Nissen LM; Tett SE
    J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug samples: friend or foe?
    Coolidge MP
    J Drugs Dermatol; 2002 Jul; 1(1):49-52. PubMed ID: 12847754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
    Schetky DH
    Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report raises questions about drug companies advertising budgets.
    AIDS Policy Law; 1999 Aug; 14(14):1, 6. PubMed ID: 11366996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical advertising as a consumer empowerment device.
    Rubin PH
    J Biolaw Bus; 2001; 4(4):59-65. PubMed ID: 12751498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychology in the prescription era: building a firewall between marketing and science.
    Antonuccio DO; Danton WG; McClanahan TM
    Am Psychol; 2003 Dec; 58(12):1028-43. PubMed ID: 14664691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.
    Manchanda P; Honka E
    Yale J Health Policy Law Ethics; 2005; 5(2):785-822. PubMed ID: 16052900
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.